Thalys Medical Technology Group Corporation (SHA:603716)

SHA:603716 Revenue

Thalys Medical Technology Group had revenue of 181.79M CNY in the quarter ending March 31, 2026, a decrease of -36.75%. This brings the company's revenue in the last twelve months to 971.32M, down -39.78% year-over-year. In the year 2025, Thalys Medical Technology Group had annual revenue of 1.08B, down -40.52%.

• Revenue (ttm): 971.32M
• Revenue Growth: -39.78%
• P/S Ratio: 4.53
• Revenue / Employee: 779.55K
• Employees: 1,246
• Market Cap: 4.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.08B	-733.73M	-40.52%
Dec 31, 2024	1.81B	-195.45M	-9.74%
Dec 31, 2023	2.01B	-302.50M	-13.10%
Dec 31, 2022	2.31B	-290.92M	-11.19%
Dec 31, 2021	2.60B	474.08M	22.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error